Literature DB >> 10523459

The natural history of type 2 diabetes. Implications for clinical practice.

B A Ramlo-Halsted1, S V Edelman.   

Abstract

This article reviews the natural history of type 2 diabetes and emphasizes that the disease is a continuum from impaired glucose tolerance and impaired fasting glucose to frank diabetes. Understanding this natural history aids the clinician in identifying those individuals most at risk for developing type 2 diabetes. Early intervention may significantly limit the severity of the microvascular and macrovascular complications of diabetes. Additionally, this article discusses oral antidiabetic agents and reviews their potential effectiveness at the different stages in the continuum to aid the clinician in developing a treatment strategy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523459     DOI: 10.1016/s0095-4543(05)70130-5

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  29 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010.

Authors:  Andrew R Zullo; David D Dore; Lori Daiello; Rosa R Baier; Roee Gutman; David R Gifford; Robert J Smith
Journal:  J Am Med Dir Assoc       Date:  2016-03-24       Impact factor: 4.669

3.  Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.

Authors:  Shigeru Okada; Edward O List; Sudha Sankaran; John J Kopchick
Journal:  Clin Proteomics       Date:  2010-06-01       Impact factor: 3.988

Review 4.  Medical care from childhood to adulthood in type 1 and type 2 diabetes.

Authors:  G Costi; S Ten; N K Maclaren
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

Review 5.  β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.

Authors:  Teresa Mezza; Francesca Cinti; Chiara Maria Assunta Cefalo; Alfredo Pontecorvi; Rohit N Kulkarni; Andrea Giaccari
Journal:  Diabetes       Date:  2019-06       Impact factor: 9.461

6.  Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study.

Authors:  Hong Wang; Nawar M Shara; Darren Calhoun; Jason G Umans; Elisa T Lee; Barbara V Howard
Journal:  Diabetes Metab Res Rev       Date:  2010-07       Impact factor: 4.876

7.  Insulin resistance in Nigerians with essential hypertension.

Authors:  T O Akande; J O Adeleye; S Kadiri
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

Review 8.  Emerging treatment options for type 2 diabetes.

Authors:  Milan K Piya; Abd A Tahrani; Anthony H Barnett
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

9.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

10.  Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence.

Authors:  NaNa Keum; Kyoung Hwa Ha; Ying Bao; Moon Jae Chung; Hyeon Chang Kim; Edward L Giovannucci
Journal:  Cancer Causes Control       Date:  2017-12-02       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.